PLD2 ablation has been shown to improve outcomes in a model of Alzheimer’s disease9, to suppress cancer growth and metastasis in a heterotopic implant model10, and to improve outcomes in thrombotic disease models in combination with PLD1 ablation4. The gene discussed is PLD2; the disease is cancer.